PARK AVENUE SECURITIES LLC
Broker-DealerPosition in CAI — Caris Life Sciences, Inc.
CIK 1071640
NEW YORK, NY
Position in CAI
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$279,417
-$220,096 QoQ
Shares Held
15,680
-43.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#152
of 246 holders
Holding Since
Sep 2025
3 quarters on record
Common Shares in CAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PARK AVENUE SECURITIES LLC holds $18,019,918 across 22 Biotechnology names. CAI ranks #18 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,198 | $5,065,652 | |
| 2 | RPRX |
Royalty Pharma plc
|
46,965 | $2,633,327 | |
| 3 | INSM |
INSMED Inc
|
9,927 | $1,058,416 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,563 | $974,593 | |
| 5 | EXEL |
Exelixis, Inc.
|
16,542 | $900,050 | |
| 6 | ARGX |
Argenx SE
|
956 | $886,948 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
3,608 | $869,419 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
10,089 | $789,666 |
All Filings in CAI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $279,417 | 15,680 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $499,513 | 27,937 | Shares | Sole | 2026-04-07 | |
| 2025-09-30 | $627,082 | 20,730 | Shares | Sole | 2025-10-23 | |
| No filing history on record for this holder in this stock. | ||||||